Paper36939319
2-5A-Mediated decay (2-5AMD): from antiviral defense to control of host RNA.
Prangley E and 1 other. Crit Rev Biochem Mol Biol, 2022. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. 2-5A-Mediated decay (2-5AMD): from antiviral defense to control of host RNA. Papers, record 36939319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36939319
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| RNA Stability | Major topic |
| Virus Diseases | Major topic |
| Viruses | Major topic |
| RNA | Major topic |
| Immunity, Innate | Major topic |
| 2',5'-Oligoadenylate Synthetase | Major topic |
| Host Microbial Interactions | Major topic |
| Interferons | |
| Breast Neoplasms | |
| 3' Untranslated Regions | |
| DNA, Intergenic | |
| Animals | |
| Introns | |
| Signal Transduction | |
| Fatigue Syndrome, Chronic | |
| Retroelements | |
| RNA, Double-Stranded | |
| Humans | |
| Prostatic Neoplasms |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F31 HL158123 | NHLBI NIH HHS | United States | F31HL158123 | PubMed | NIH RePORTER |
| R01 GM110161 | NIGMS NIH HHS | United States | R01GM110161 | PubMed | NIH RePORTER |
| T32 GM007388 | NIGMS NIH HHS | United States | T32GM007388 | PubMed | NIH RePORTER |
References133
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11967338 | Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. | J Virol | 2002 | https://conductscience.org/library/papers/11967338 | PubMed |
| 2 | 34342578 | Endomembrane targeting of human OAS1 p46 augments antiviral activity. | Elife | 2021 | https://conductscience.org/library/papers/34342578 | PubMed |
| 3 | 25925578 | Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25925578 | PubMed |
| 4 | 17604869 | Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L. | Virus Res | 2007 | https://conductscience.org/library/papers/17604869 | PubMed |
| 5 | 26401041 | Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms. | J Virol | 2015 | https://conductscience.org/library/papers/26401041 | PubMed |
| 6 | 22875977 | RNase L triggers autophagy in response to viral infections. | J Virol | 2012 | https://conductscience.org/library/papers/22875977 | PubMed |
| 7 | 18575461 | Interferon-inducible antiviral effectors. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/18575461 | PubMed |
| 8 | 31494033 | Concerted 2-5A-Mediated mRNA Decay and Transcription Reprogram Protein Synthesis in the dsRNA Response. | Mol Cell | 2019 | https://conductscience.org/library/papers/31494033 | PubMed |
| 9 | 19079236 | The unfolded protein response signals through high-order assembly of Ire1. | Nature | 2009 | https://conductscience.org/library/papers/19079236 | PubMed |
| 10 | 21767385 | Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. | Genome Biol | 2011 | https://conductscience.org/library/papers/21767385 | PubMed |
| 11 | 2472548 | [Degradation of messenger RNA, ribosomal RNA and 2-5A-dependent inhibition of protein biosynthesis]. | Mol Biol (Mosk) | 1988 | https://conductscience.org/library/papers/2472548 | PubMed |
| 12 | 21182542 | Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy. | J Gastroenterol Hepatol | 2011 | https://conductscience.org/library/papers/21182542 | PubMed |
| 13 | 23109342 | RNase L induces autophagy via c-Jun N-terminal kinase and double-stranded RNA-dependent protein kinase signaling pathways. | J Biol Chem | 2012 | https://conductscience.org/library/papers/23109342 | PubMed |
| 14 | 12471243 | The protein kinase complement of the human genome. | Science | 2002 | https://conductscience.org/library/papers/12471243 | PubMed |
| 15 | 25069772 | Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. | EMBO J | 2014 | https://conductscience.org/library/papers/25069772 | PubMed |
| 16 | 15855350 | OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. | Diabetes | 2005 | https://conductscience.org/library/papers/15855350 | PubMed |
| 17 | 14554250 | Diagnostic evaluation of 2', 5'-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan. | Microbes Infect | 2003 | https://conductscience.org/library/papers/14554250 | PubMed |
| 18 | 25520563 | Deep Sequencing of Serum Small RNAs Identifies Patterns of 5' tRNA Half and YRNA Fragment Expression Associated with Breast Cancer. | Biomark Cancer | 2014 | https://conductscience.org/library/papers/25520563 | PubMed |
| 19 | 18575592 | Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer. | PLoS One | 2008 | https://conductscience.org/library/papers/18575592 | PubMed |
| 20 | 31494035 | RNase L Reprograms Translation by Widespread mRNA Turnover Escaped by Antiviral mRNAs. | Mol Cell | 2019 | https://conductscience.org/library/papers/31494035 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41618367 | PRRSV Nsp11 antagonizes host antiviral immune response by reducing OAS1 and RNase L expressions. | BMC Vet Res | 2026 | https://conductscience.org/library/papers/41618367 | PubMed |
| 41457140 | Activated oligoadenylate synthetase-ribonuclease L pathway promotes endothelial pyroptosis and impairs diabetic wound healing via thioredoxin-interacting protein m6A methylation. | Mol Biomed | 2025 | https://conductscience.org/library/papers/41457140 | PubMed |
| 40480194 | Finding a foothold to fight: New insights into the viral RNA sensing and activation mechanism of OAS2. | Mol Cell | 2025 | https://conductscience.org/library/papers/40480194 | PubMed |
| 40233983 | RNase L produces tRNA-derived RNAs that contribute to translation inhibition. | RNA | 2025 | https://conductscience.org/library/papers/40233983 | PubMed |
| 39727035 | The Unusual Role of Ribonuclease L in Innate Immunity. | Wiley Interdiscip Rev RNA | 2024 | https://conductscience.org/library/papers/39727035 | PubMed |
| 38334619 | Significant Variations in Double-Stranded RNA Levels in Cultured Skin Cells. | Cells | 2024 | https://conductscience.org/library/papers/38334619 | PubMed |
| 38321453 | Mechanisms and consequences of mRNA destabilization during viral infections. | Virol J | 2024 | https://conductscience.org/library/papers/38321453 | PubMed |
| 37751211 | The Many Faces of Oligoadenylate Synthetases. | J Interferon Cytokine Res | 2023 | https://conductscience.org/library/papers/37751211 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36939319
GET https://conductscience.org/api/papers/v1/36939319/references?page=2